Related Experiment Video
Updated: Nov 4, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
526
Rethinking Idiopathic Pulmonary Fibrosis
Justin M Oldham1, Carlo Vancheri2
1Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, 4150 V Street Suite 3400, Sacramento, CA 95817, USA.
Clinics in Chest Medicine
|May 24, 2021
Summary
Idiopathic pulmonary fibrosis (IPF) understanding has evolved significantly since the 1960s. Research advancements have improved diagnosis and treatment, offering new hope for patients with this lung disease.
Area of Science:
- Pulmonology and Respiratory Medicine
- Medical Research History
Background:
- Idiopathic pulmonary fibrosis (IPF) is a severe lung disease with a complex history.
- Early research in the 1960s laid the foundation for understanding IPF.
- Progress has continually reshaped diagnostic and treatment approaches.
Purpose of the Study:
- To review the historical evolution of understanding Idiopathic pulmonary fibrosis (IPF).
- To discuss advancements in IPF pathogenesis, diagnosis, and treatment strategies.
- To highlight how research and clinical experience have transformed IPF care.
Main Methods:
- Literature review of research and clinical experience over the past 50+ years.
- Analysis of the historical progression of IPF knowledge.
- Synthesis of findings on IPF pathogenesis, diagnostics, and therapeutics.
Main Results:
- Understanding of IPF pathogenesis has significantly advanced.
- Diagnostic methods have become more accurate and less invasive.
- Treatment options for IPF have become more effective.
Conclusions:
- The historical trajectory of IPF research demonstrates substantial progress.
- Current understanding challenges previous diagnostic and treatment paradigms.
- An era of greater diagnostic certainty and improved therapeutic outcomes is emerging for IPF patients.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.5K
01:30Pulmonary Hypertension: Classification and Pathogenesis
370
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
370
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.1K
01:20COPD: Pathogenesis and Clinical Features
1.5K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
01:22Chronic Obstructive Pulmonary Disease
1.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K